HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels

BACKGROUND/AIM: Direct-acting antivirals (DAAs) have improved the treatment of HCV-positive kidney transplant recipients (KTRs). However, their medium-term follow-up effects on graft function are conflicting. This study aimed to analyze how the interplay between DAAs, calcineurin inhibitors (CNI), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rendina, Maria, Paoletti, Ernesto, Labarile, Nunzia, Marra, Antonella, Iannone, Andrea, Castellaneta, Antonino, Bussalino, Elisabetta, Ravera, Maura, Schena, Antonio, Castellaneta, Nicola M., Barone, Michele, Simone, Simona, Gesualdo, Loreto, Di Leo, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486264/
https://www.ncbi.nlm.nih.gov/pubmed/36147292
http://dx.doi.org/10.1177/20406223221117975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486264/
https://www.ncbi.nlm.nih.gov/pubmed/36147292
http://dx.doi.org/10.1177/20406223221117975

Ejemplares similares